Ibrance
NDC 63539-284, palbociclib, tablet, film coated, from U.S. Pharmaceuticals.
- Product NDC
- 63539-284
- Status
- Listed
- Labeler
- U.S. Pharmaceuticals
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA212436
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/63539-284 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PALBOCICLIB75 mg/1
Pharmacologic classes
Cytochrome P450 3A Inhibitors [MoA]; Kinase Inhibitor [EPC]; Kinase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 63539-284-03 | 63539028403 | 3 DOSE PACK in 1 CARTON (63539-284-03) / 7 TABLET, FILM COATED in 1 DOSE PACK (63539-284-07) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/89a142d5-7e61-48bf-9e77-e2cd124c4792
Use it
Look up 63539-284 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/63539-284 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 63539-284. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.